PMID: 16636384Apr 26, 2006Paper

The prevalence of diabetic retinopathy in subjects with type 2 diabetes of one year and less duration

Georgian Medical News
D S MetrreveliM Z Margvelashvili

Abstract

Cases of diabetic retinopathy (DR) at the preclinical stage of diabetes mellitus type 2 (DMT2) can't be explained considering the conventional theory on etio-pathogenesis of diabetic microangiopathy. The present research aimed to study the prevalence of DR among the patients with the newly diagnosed DMT2 and to analyze the possible causes of formation of this complication in the period preceding the period of hyperglycemia. According to the data of the present study the DR prevalence in the patients with newly diagnosed DMT2 equals to 16,4%. The chance of the existence of DR among the patients over 45 is 2,6 times higher than among those of 45 and younger. Proceeding from the results of the present study the assumption is made on the presence of pathogenic mechanisms conditioning initiation of diabetic microvascular pathology before stabilization of hyperglycemia at the stage of the impaired glucose tolerance.

Related Concepts

Related Feeds

Autoimmune Diabetes & Tolerance

Patients with type I diabetes lack insulin-producing beta cells due to the loss of immunological tolerance and autoimmune disease. Discover the latest research on targeting tolerance to prevent diabetes.

Related Papers

Journal of Nursing Scholarship : an Official Publication of Sigma Theta Tau International Honor Society of Nursing
Esther C GallegosMarco Vinicio Gomez-Meza
Trends in Endocrinology and Metabolism : TEM
T A ChowdhuryS C Bain
Aviation, Space, and Environmental Medicine
Lawrence W SteinkrausAllan Golding
© 2022 Meta ULC. All rights reserved